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Abstract—Acute thermal trauma is well known to produce evidence of a “systemic
inflammatory response” in vivo, as manifested by evidence of complement activation,
appearance in plasma of a variety of inflammatory factors, and development of
multi-organ injury. The current studies were focused on acute thermal injury of
rat skin and factors responsible for accompanying activation of blood neutrophils.
Acute thermal injury of rat skin resulted in a time-dependent loss of L-selectin
and up-regulation of Mac-1 (CD11b/CD18) on blood neutrophils, with no changes
in LFA-1 (CD11a/CD18). The loss of L-selectin was prevented by blockade of
C5a but not by blockade of the a-chemokine, macrophage inflammatory protein-2
(MIP-2). C5a, the a chemokines, MIP-2 and keratinocyte-derived cytokine (KC),
and platelet activating factor (PAF) contributed to up-regulation of blood neutrophil
Mac-1. Blocking interventions against these mediators also blunted the degree of
neutropenia developing after thermal trauma. These data suggest that activation of
blood neutrophils after thermal trauma is related to the role of several chemotactic
mediators. These studies may provide clues regarding factors responsible for de-
velopment of the “systemic inflammatory response syndrome” after thermal injury
in the experimental model employed.
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INTRODUCTION
Chemoattractants induce a range of neutrophil activation events, including polar-
ization, chemotaxis, oxygen free-radical production, degranulation, up-regulation
of neutrophil CD lib/CD 18 (Mac-1) and loss of L-selectin (1–3). Furthermore,
intravenous infusion of chemotactic factors induces a rapid and profound neu-
tropenia followed by leukocytosis (4). Neutropenia may result from a cell “stiff-
ening,” leading to trapping of these cells within the narrow confines of the pul-
monary microvasculature (5). Neutropenia followed by neutrophilia also occurs
after thermal injury and appears to be complement-mediated (6).
Emigration of blood neutrophils into an inflammatory site requires acti-
vation of both neutrophils and vascular endothelial cells and adhesive inter-
actions between the two cell types (7, 8). These leukocyte-endothelial adhe-
sive events can be linked to several families of molecules: the B2-integrins,
the immunoglobulin (Ig) superfamily, and the selectin family (9, 10). L-selectin
(and other selectins) appears to be important in the earliest contact between the
leukocyte and the endothelium, being responsible for the “rolling” phenomenon
(11). Rolling slows down the progress of leukocytes in blood vessels, particu-
larly venules, and allows additional adhesive mechanisms to operate. The B2-
integrins, CD11a/CD18 (LFA-1) and CD lib/CD 18, (Mac-1, CR3), bind to the
adhesion molecule immunoglobulin family member, ICAM-1 (12, 13) which
can be upregulated by exposure of the endothelium to lipopolysaccharide and
cytokines (e.g., TNFa, IL-1B) (14). Under some situations this up-regulation
appears to be complement-dependent (15). As neutrophils become activated by
a chemoattractant, CD11b/CD18 is up-regulated and L-selectin is shed from the
neutrophil membrane (16, 17). Thus, this pair of adhesion molecules appears
to function in a coordinated fashion during neutrophil activation. Increased sur-
face expression of CD11b/CD18 on circulating neutrophils after thermal injury
has been described previously (18, 19), the outcome of which presumably facil-
itates adherence to endothelial cells. Treatment with antibodies directed against
either neutrophil adhesion molecules (CD11b, CD18, L-selectin) or endothelial
cells adhesion molecules (ICAM-1, E-selectin) has reduced burn-induced dermal
injury as well as lung vascular injury in the experimental model (20, 21).
It is now reasonably well accepted that thermal injury induces a “systemic
inflammatory response syndrome,” as defined by activation of the complement
system, appearance in plasma of a variety of inflammatory mediators, and activa-
tion of blood neutrophils. Activation of blood neutrophils is likely to predispose
to induction of endothelial injury. The relationship between the appearance of
mediators in the plasma and activation of blood neutrophils has not been estab-
lished. The present study addresses the hypothesis that there is a relationship
between thermal injury-induced chemotactic factor release and subsequent neu-
trophil activation. We used antibodies directed against C5a, keratinocyte-derived
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cytokine (KC), macrophage inflammatory protein-2 (MIP-2), and platelet acti-
vating factor receptor antagonist (PAF-Ra) to define the requirements for these
chemotactic factors in thermal injury-induced expression of adhesion molecules
(L-selectin and B2-integrins) on blood peripheral neutrophils of rats. Evidence
is provided that after thermal injury, chemotactic factors function to cause time-
dependent activation of blood peripheral neutrophils, as reflected by loss of
L-selectin and up-regulation of CD11b/CD18.
MATERIALS AND METHODS
Animal Model of Thermal Injury. The rat burn model used is well established in our labo-
ratory (6). Adult male (300 to 350 g) specific pathogen-free Long Evans rats were purchased from
Charles Rivers Laboratories, Portage, Michigan. Briefly, intraperitoneal ketamine (50 mg/kg body
weight) (Fort Dodge Laboratories, Inc., Fort Dodge, Iowa) and intramuscular xylazine (13 mg/kg
body weight) (Loyd Laboratories, Shenandoah, Iowa) were used for continuous anesthesia and seda-
tion (up to 4 h). After induction of anesthesia, the animals were shaved and then the lower flanks
exposed to 70°C water for 30 s resulting in a deep second-degree burn. The burn was covered with
sterile gauze and rats were placed in separate cages. The total body surface area burned was 28–30%,
and the thermal injury was non-lethal. At various time points (as indicated) after thermal injury,
blood was collected from the posterior vena cava. Then the rats were killed by excess ketamine.
Control (sham burn) animals were exposed to water at 22°C. All experiments in accord with the
standards in “The Guide for the Care and Use of Laboratory Animals” (DHEW Pub. No. (NIH)
78/23, revised 1978) and were supervised by veterinarians from the Unit for Laboratory Animal
Care of the University of Michigan Medical School.
Leukocyte Counts. Long Evans rats (300–350 g) were kept under anesthesia for the dura-
tion of the experimental procedure. Peripheral venous blood was obtained from the tail vein using
Unopette microcollection system (Becton Dickinson, Rutherford, New Jersey) at time 0 and 30 min,
1, 2, and 4 h after thermal injury and treatment (interventions). After allowing red cells to hemolyze
(10 min), the white cells were counted using a hemocytometer. Numbers of polymorphonuclear neu-
trophils (PMN) were determined through manual differential counts (200 cells) from blood smears
stained with Diff-Quick Fixative (Baxter Healthcare Corporation, McGraw Park, Illinois).
Reagents. Unless otherwise indicated, all reagents were purchased from Sigma Co. (St.
Louis, Missouri).
Agents and Strategies for in Vivo Blocking of Thermal Injury-Induced Changes in Adhesion
Molecules. The dosing schedules for blocking of rat C5a, PAF-R, keratinocyte derived cytokines
(KC) and macrophage inflammatory protein-2 (MIP-2) were determined on the basis of recent pub-
lications (22–25). Interventions were given by an intravenous infusion.
For obtaining antibodies to rat C5a, rabbits were immunized with rat C5a obtained from
zymosan-activated rat serum as described elsewhere (26). After multiple boostings, serum was
obtained and rabbit IgG anti-C5a was purified by the use of a protein G sepharose column (Phar-
macia Biotech AB, Uppsala, Sweden) and dialyses against PBS (22). Rats received an intravenous
infusion (500 ml) of either rabbit IgG anti-C5a (1 mg/kg) or purified rabbit IgG (1 mg/kg) (positive
control) in normal saline, immediately after thermal injury. PAF receptor antagonist (PAF-Ra) was
kindly provided by Dr. Jeffrey S. Warren (WEB2086) (Boehringer-Ingelheim Pharmaceuticals, Inc.,
Ridgefield, Connecticut). Rats received an intravenous infusion (500 ml) of either PAF-Ra (50 mg/kg)
(23) in normal saline or the vehicle, immediately after thermal injury. The anti-mouse KC was a
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gift from Dr. Daniel G. Remick, (Department of Pathology, University of Michigan). Polyclonal
antibody to recombinant mouse KC (rKC) was raised in rabbits by subcutaneous immunization with
rKC in Hunters Titermax. This antibody reduces glycogen-induced peritoneal neutrophil recruitment
in the rat (unpublished). Rats were intravenously infused with either 1.0 ml of a 1:5 rabbit immu-
nized serum dilution or normal rabbit serum, 30 min before thermal injury. Polyclonal rabbit anti-rat
MIP-2 was raised against the rat recombinant 7.9-kDa expression product (25). New Zealand White
rabbits were repeatedly immunized with 1.0 mg MIP-2 emulsified in complete and subsequently
incomplete Freund’s adjuvant as explained elsewhere (25). Briefly, the IgG fraction of the rabbit
anti-MIP-2 antiserum was obtained by chromatography on protein G-Sepharose (GammaBind G
Sepharose; Pharmacia). Affinity-purified anti-MIP-2 was infused (1 mg/kg) intravenously (500 ml)
into the rats, immediately after thermal injury.
Antibodies for Flow Cytometry Studies
Selectins: Antibody against rat L-selectin (HRL-3) was generated in hamsters according to
previously published methods and has been shown to inhibit neutrophil binding to activated endo-
thelium (27). The isotype matched control consisted of cells stained with hamster IgG (ImmunoPure,
Pierce, Rockford, Illinois) and R-phycoerythrin goat F(ab')2 anti-hamster IgG (Caltag Laboratories,
San Francisco, California) labeled secondary antibody.
B2-Integrins: Monoclonal antibody reactive with rat CD11a (WT-1), of the IgG2a subclass,
was generated by immunization of mice with rat splenocytes according to recently published meth-
ods (28). WT-1 has been demonstrated to recognize a leukocyte epitope of 160 to 170 kDa and did
not react with the B-subunit of leukocyte function-associated antigen-1 (LFA-1) (95 to 100 kDa). This
antibody has been shown to inhibit binding of stimulated lymphocytes to cultured rat high endothelial
cells (28). A monoclonal antibody (lB6c) to rat CD11b was generated by immunization of BALB/c
mice with rat peritoneal neutrophils and subsequent fusion of splenocytes from these mice with NS-
1 myeloma cells. This antibody is described in detail elsewhere (29) and has been shown to attenuate
neutrophil adhesion in vitro of rat neutrophils to rat microvascular endothelial cells. Monoclonal anti-
body to CDI8 (WT-3) is purified IgG1 prepared by affinity chromatography on Protein A from ascites
(30). It has been shown to inhibit homotypic aggregation of PHA blasts and also blocks binding of rat
lymphocytes to purified rat ICAM-1. R-Phycoerythrin-conjugated AffiniPure F(ab')2 Fragment Goat
anti-mouse IgG (Immunotech, Inc., Westbrook, Maine) was employed as secondary antibody. The iso-
type matched control consisted of cells stained with MOPC-21 (mouse IgG1) and phycoerythrin labeled
secondary antibody. The concentration of the antibodies employed was 10 Mg/ml.
Measurement of Adhesion Molecule Expression by Flow Cytometry. In animals from all
groups, adhesion molecule expression was determined on peripheral blood neutrophils by indirect
immunofluorescence utilizing whole blood samples from the posterior vena cava (31). Blood sam-
ples were collected in heparin (10 U/ml) and were immediately fixed in 0.5% paraformaldehyde
until all samples were collected. Duplicate 200 ml aliquots of blood were then incubated for 15
min at room temperature with an equal volume of 10 mg/ml of murine monoclonal antibodies spe-
cific for the desired adhesion molecule (WT-1 for rat CD11a; 1B6c for rat CD11b; WT-3 for rat
CD18). An isotype matched control consisted of cells stained with MOPC-21 (mouse IgG1). The
samples were washed twice in 1.0 ml Dulbecco’s phosphate-buffered saline (DPBS) and were then
incubated with 100 ml of 1:50 dilution of the secondary antibody (phycoerythrin conjugated) for
15 min at room temperature and washed once in 1.0 ml DPBS. Red cells were lysed in 2.0 ml of
FACS lysing solution (Becton Dickinson, San Jose, California) for 15 min at room temperature in
the dark. The samples were then washed once in DPBS, resuspended in 1% paraformaldehyde and
stored overnight at 4°C. Monoclonal antibody binding of gated neutrophil populations (identified by
forward versus right angle light scatter characteristics) were measured on a FACScan Flow Cytom-
etry System (Becton Dickinson, San Jose, California) in which 10,000 cells per determination were
counted and the extent of binding was analyzed using PC-LYSIS software (Becton Dickinson). The
results are expressed as percentage of controls.
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Statistical Analysis. All values were expressed as mean ± SEM unless otherwise indicated.
Statistical significance was defined as P < 0.05. The data were analyzed using one-way analysis of
variance and differences between individual group means and control were analyzed using Student’s
t-test.
RESULTS
Expression of Neutrophil Adhesion Molecules after Thermal Injury. By
the use of monoclonal antibodies, flow cytometry was employed to moni-
tor blood neutrophil expression of L-selectin and B2-integrins (CD11a/CD18,
CD11b/CD18) after thermal injury to rat skin, as described above. Analyses were
performed on whole blood samples to avoid the activating effects of leukocyte
purification procedures. Levels of L-selectin and B2-integrins were studied at 30
min, 1, 2 and 4 h after thermal injury. The isotype-matched controls consisted
of cells stained with MOPC-21 (mouse IgG1). As shown in Figure 1, within 30
min after skin burn, thermal trauma induced a reduction in L-selectin expression
Fig. 1. Thermal injury-induced time-dependent changes of adhesion molecule (L-selectin, B2-in-
tegrins) expression on blood neutrophils of rats, as measured by flow cytometry using monoclonal
antibodies. Changes in the expression of adhesion molecules on neutrophils obtained from thermally
injured rats were compared to changes observed on neutrophils obtained from control (sham burn)
animals and expressed as percent of control. At least three animals per time point were used. *P <
0.004 compared to control animals.
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in blood neutrophils, resulting in a 15% (P < 0.0001) decrease (as determined
by HRL-3 binding). Expression remained depressed for the entire period (4 h)
of observation. A coincidental increase of 20% (P < 0.0004) in blood neutrophil
expression of CD11b(as determined by lB6c binding) was observed at the ear-
liest time point (30 min). Expression of CD11b rose to 82% (P < 0.0000002)
by 4 h. Up-regulation of neutrophil CD18 (measured by WT-3 binding) was
detectable at 1 hr (17% increase) (P < 0.004), reaching a maximum at 2 h (52%
increase, P < 0.000003) and slightly declining thereafter. CD18 did not return
to normal levels over the 4 h period of observation. As expected, no signifi-
cant change of neutrophil CD11a expression (determined by WT-1 binding) was
found during these studies. Thus, thermal injury induces early and persistent neu-
trophil activation, as reflected by L-selectin down-regulation and up-regulation
of CDllb/CD18 in the absence of changes in CD11a.
Protocols for Treatment of Experimental Animals. The finding of neutro-
phil down-regulation of L-selectin expression and up-regulation of CD11b/CD18
expression suggested the probability of inflammatory mediators being respon-
sible for neutrophil activation. Chemotactic factors are known to induce similar
changes in vitro (16) and it was already demonstrated in plasma the presence
of neutrophil chemotactic activity, 30 min after thermal injury (6). In order to
analyze the requirements of chemotactic factors on thermal injury-induced neu-
trophil expression of adhesion molecules, the animals were divided into 4 groups
and submitted to an intravenous injection of antibodies directed to several dif-
ferent mediators: 500 ml of either rabbit IgG anti-C5a (1 mg/kg) or purified pre-
immune rabbit IgG (positive control), injected intravenously immediately after
thermal injury; 500 ml of either PAF-Ra (50 mg/kg) or normal saline, injected
intravenously immediately after thermal injury; 1.0 ml of rabbit serum anti-KC
or normal rabbit serum, injected intravenously 30 min before thermal injury, or
500 ml of anti-MIP-2 (1 mg/kg) or normal saline, injected intravenously imme-
diately after thermal injury. Blood was drawn from the posterior vena cava at 30
min, 1, 2 and 4 h after thermal injury and flow cytometry analysis was under-
taken.
Inhibition of L-selectin Changes by Treatment with Anti-C5a and Anti-
MIP-2. The intravenous injection of anti-C5a, completely prevented the loss
of neutrophil L-selectin down-regulation after thermal injury (Figure 2). Why
there was a statistically significant increase (16%, P < 0.00008) in neutrophil
L-selectin at 60 min post thermal injury is not clear. Treatment with anti-MIP-2
failed to prevent the loss of neutrophil L-selectin, suggesting that, in contrast to
C5a, MIP-2 does not appear to play a role in L-selectin down-regulation.
Inhibition of CD11b Expression by Blocking of C5a, KC, MIP-2 or
PAF-R. Treatment with anti-C5a greatly reduced up-regulation of neutrophil
CD11b expression after thermal injury at all intervals of time studied (Figure
3A). At 30 and 60 min, levels of CD11b dropped below basal levels of expres-
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Fig. 2. Effect of blocking interventions on blood neutrophils L-selectin by intravenous infusion of
anti-C5a (1 mg/kg) or anti-MIP-2 (1 mg/kg) on thermal injury-induced loss of L-selectin expression.
L-selectin was determined by HRL-3 antibody binding employing flow cytometry. Changes in the
expression of adhesion molecules on neutrophils obtained from thermally injured rats were compared
to changes observed on neutrophils obtained from control (sham burn) animals and expressed as
percent of control. At least three animals per time point were used, for each treatment group. *P <
0.005 compared to control animals; #P < 0.002 compared to burn animals.
sion; at 2 h CD11b expression was normal, while at 4 h there was only about
20% up-regulation of CD11b in contrast to the positive controls, which, at 4
h, showed approximately 80% increase in CD11b. Thus, C5a seems to play a
major role in up-regulation of neutrophil CD11b expression after thermal injury.
Treatment with PAF-Ra completely abolished up-regulation of CD11b during
the 4 h period of observation (Figure 3A). Treatment with either anti-KC or
anti-MIP-2 failed to interfere with thermal injury-induced up-regulation of neu-
trophil CD11b expression at early time points (30 min and 1 h) but at 2 and 4
h either treatment reduced (40–50%, P < 0.0009) CD11b up-regulation (Figure
3B). Thus, C5a, PAF, KC and MIP-2 are required for full activation (defined by
increased expression of CD11b) of blood neutrophils after thermal injury.
Requirements for C5a, KC, MIP-2 and PAF in Up-regulation of Neutrophil
CD18. Experiments were also carried out to determine to what extent block-
ing of various inflammatory mediators would affect up-regulation of blood neu-
trophil CD18 four h after thermal injury to the skin. The data from these exper-
iments are shown in Figure 4A, B. When rats were treated with anti-C5a, CD18
378 Piccolo et al.
Fig. 3. Effect of blocking interventions on blood neutrophil CD11b expression by intravenous infu-
sion of anti-C5a (1 mg/kg) or PAF-Ra (1 mg/kg) (frame A) and anti-KC (1 ml rabbit antiserum) or
anti-MIP-2 (1 mg/kg) (frame B) after thermal injury. CD11b was measured by lB6c binding using
flow cytometry. Changes in the expression of adhesion molecules on neutrophils obtained from ther-
mally injured rats were compared to changes observed on neutrophils obtained from control (sham
burn) animals and expressed as percent of control. At least three animals per time point were used,
for each treatment group. *P < 0.001 compared to control animals; #P < 0.005 compared to burn
animals.
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Fig. 4. Effect of blocking interventions on blood neutrophil CD18 expression by intravenous infu-
sion of anti-C5a (1 mg/kg) or PAF-Ra (1 mg/kg) (frame A) and anti-KC (1 ml rabbit antiserum) or
anti-MIP-2 (1 mg/kg) (frame B) after thermal injury. CD18 was measured by WT-3 binding using
flow cytometry. Changes in the expression of adhesion molecules on neutrophils obtained from ther-
mally injured rats were compared to changes observed on neutrophils obtained from control (sham
burn) animals and expressed as percent of control. At least three animals per time point were used,
for each treatment group. *P < 0.001 compared to control animals; #P < 0.009 compared to burn
animals.
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aCompared with sham (P < 0.005).
bCompared with the burn positive control group at the same period of lime (P < 0.01).
cCompared with previous time point (P < 0.01).
levels fell below those of MOPC-21-treated rats by 15% (P < 0.003) at 30 min.
At 60 min, CD18 levels were at baseline. At 2 and 4 h, in anti-C5a treated ani-
mals, levels of CD18 were increased by 24% (P < 0.001) and 26% (P < 0.0005),
respectively, but these levels were much reduced when compared to positive con-
trols (Figure 4A). In the case of treatment with PAF-Ra, at all time points, there
was complete abolition of up-regulation of CD18 in thermally injured rats (Fig-
ure 4A). Treatment with anti-KC or anti-MIP-2 did not interfere with thermal
injury-induced up-regulation of neutrophil CD18 expression at the early time
points (30 min and 1 h) but treatment with anti-KC reduced CD18 expression
by 28% (P < 0.0003) and 34% (P < 0.00002) at 2 and 4 h, respectively (Fig-
ure 4B). This pattern was similar to that observed at 2 and 4 h, when rats were
treated with anti-MIP-2 (Figure 4B).
Effects of Interventions on Changes in Blood Neutrophil Counts. Periph-
eral blood was obtained before thermal injury, and at 0.5, 1, 2, and 4 h after ther-
mal trauma. Total blood counts were determined by differential counts to deter-
mine precise neutrophil levels in blood as a result of interventions. As shown
by the data in Table 1, in the sham controls a slight neutropenia developed at
30 min (a 25% fall), with blood counts stabilizing thereafter. In thermal injury
animals, at 30 min, there was a 77% fall in numbers of blood neutrophils, fol-
lowed by gradual return. At 4 h post burn, there was a 2-fold increase in the
numbers of circulating blood neutrophils. In thermally injured animals treated
with anti-C5a, the degree of neutropenia was not as severe (54% drop as com-
pared to the thermal injury group), and there was a gradual increase at 4 h in
the number of neutrophils (1.9-fold increase above time zero). Statistically, there
was a significant attenuation in the degree of neutropenia in animals treated with
anti-C5a when compared to thermal injury control animals. In the group treated
with PAF-Ra, thermal injury lead to a 66% fall in blood neutrophils at 30 min.
In this group, the treatment prevented the increase in neutrophil counts at 4 h.
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When animals were treated with antibody to KC, the blood neutrophil count at
30 min fell by 61%, again indicating an attenuation in the level of neutrope-
nia as a result of this treatment. At 4 h, blood neutrophil counts were 1.6-fold
above time zero. Finally, in animals treated with antibody to MIP-2, the blood
neutrophil count fell by 59% at 30 min and at 4 h the blood neutrophil count
was 1.7 above the baseline. These data indicate that, of the various interven-
tions employed, each of which reduced up-regulation of neutrophil CD11b and
CD18 after thermal injury, these treatments also attenuated the degree of neu-
tropenia developing 30 min after thermal injury. Furthermore, PAF-Ra treatment
also resulted in complete prevention of the thermal injury-related granulocytosis
observed at 4 h post burn.
DISCUSSION
Activation of the complement system following thermal injury has been
described in the experimental setting as well as in human patients (6, 32, 33), and it
has become clear that the release into the circulation of biologically active inflam-
matory mediators may be harmful to the host. Experimental studies revealed that
thermal injury to the skin results in development of secondary injury to the lungs.
Development of this injury could be related to a requirement for the complement
system, since complement-depleted animals did not develop pulmonary injury as
a consequence of skin burns (6). It was also observed that the complement acti-
vation resulted in the appearance in plasma of chemotactic activity (presumed to
be due to C5a), an event which occurred at 30 min post burn and which was paral-
leled by a transient neutropenia and accumulation of neutrophils in lung capillaries.
Subsequently, there was gradual development of lung microvascular injury within
three to four hr after thermal injury (6). Since the development of lung injury could
be related to pulmonary accumulation of blood neutrophils and their production of
toxic oxygen metabolites, it was assumed that C5a might be involved in the devel-
opment of secondary lung injury (6). C5a could activate blood neutrophils, causing
up-regulation of neutrophil adhesion molecules, aggregation and adhesive accu-
mulation of these cells in lung capillaries, and destruction of vascular endothelial
cells by oxidants released by activated neutrophils. The recent availability of anti-
body to purified rat C5a and to other mediators have allowed direct experiments
to be carried out in order to assess mediators responsible for activation of blood
neutrophils following thermal injury.
Some of the most intriguing findings are the differences in mediator require-
ments for activation of blood neutrophils. C5a, but not macrophage inflam-
matory protein-2 (MIP-2), was required for loss of neutrophil L-selectin. C5a
also appeared to be involved in post burn up-regulation of the B2-integrin,
CDllb/CD18. In this regard, it appears that platelet activating factor (PAF) has
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a functional profile similar to that of C5a. Both the chemokine KC (keratinocyte-
derived cytokine), which is a member of the IL-8 family of a-chemokines, and
the chemokine MIP-2, also a member of the a-chemokine family, did not appear
to affect blood neutrophil activation in the early phases (up to 60 min) post burn.
However, these chemokines were shown to be involved in the up-regulation of
CD11b/CD18 (Mac-1) at later time intervals. Treatment of experimental animals
with antibody against KC or MIP-2 almost completely attenuated the up-regulation
of CD11b/CD18 at four h after thermal injury. These observations may suggest that
C5a and PAF play a key role in the early activation of blood neutrophils, poten-
tially affecting other neutrophil functions such as adhesion (via CD11b/CD18) to
ICAM-1 on the lung vascular endothelium, resulting in production by activated
neutrophils of toxic oxygen metabolites. At later time points, KC, MIP-2 and PAF
also seem to play important roles in neutrophil activation post burn.
It is unclear why L-selectin downregulation was prevented by blockade of
C5a but not by blockade of MIP-2, while blockade of either molecule prevented
up-regulation of CD11b/CD18. It may be that MIP-2 is generated in rather small
amounts in the first 2 h after thermal injury, whereas substantial production of
C5a had occurred by this time point. Cell activation of neutrophils resulting
in shedding of L-selectin is thought to be due to events leading to cathepsin
activation and cleavage of L-selectin near its outer transmembrane region (34).
Up-regulation of CD11b/CD18 appears to be due to fusion of secondary cyto-
plasmic granules to the cell membrane, resulting in the appearance of Mac-1 at
the outer surface of the neutrophil cell membrane. Accordingly, it might be pre-
dicted that rat MIP-2, in contrast to C5a, does not cause activation of neutrophil
cathepsin which results in cleavage of the N-terminal region of L-selectin (34).
One of the other interesting facets of these data is the fact that, under the con-
ditions employed, blockade of the C5a, KC, MIP-2 or PAF-R resulted in nearly
total suppression in up-regulation of Mac-1 at 2 and 4 h after thermal injury.
This suggests that these mediators may function in a sequential manner, each
one depending on another to bring about the full biological response. In other
words, it may be that C5a is necessary for chemokine and PAF expression and
that blockade of either one may interrupt steps that lead in vivo to up-regulation
of Mac-1. It is difficult at present, to determine whether sequential engagement
of these mediators is occurring or if engagement is occurring simultaneously.
Systemic neutrophil activation by C5a has been suggested to occur in ther-
mally injured patients as well. Increased content of the complement receptor CR3
(Mac-1) has also been observed on blood neutrophils during the first 5 days after
thermal injury (18). It was suggested that this may be C5a-mediated because
of systemic complement activation and suppressed in vitro responses of blood
neutrophils to zymosan(complement)-activated serum (18). Similar observations
and suggestions were made by Nelson and coworkers who noticed up-regula-
tion of CR3 (19) and down-regulation of C5a receptors on blood neutrophils of
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thermally injured patients (35). Engagement of adhesion molecules other than
L-selectin and B2-integrins has also been observed in thermally injured animals.
Vascular injury at the dermal burn site in rats was shown to require involve-
ment of Mac-1, ICAM-1 and E- and L-selectin (20). In the same study, develop-
ment of lung injury secondary to skin burns in rats was demonstrated to require
Mac-1 as well as LFA-1 (CDlla/CD18). Other adhesion molecules involved in
secondary lung microvascular injury included ICAM-1 and E- and L-selectin.
Whether development of acute lung microvascular injury following skin burns
is related to chemoattractant-mediated activation of blood neutrophils remains
to be elucidated. Because of their immediate activating effects on blood neu-
trophils, C5a and PAF may seem particularly strong candidates. That increased
blood neutrophil adhesiveness can result in accumulation of neutrophils in lungs
has recently been suggested and can also be deducted from our current observa-
tions of circulating neutrophils during burn injury. Fried and colleagues studied
changes in blood neutrophil adhesiveness and aggregation in thermally injured
mice (36). Increases in adhesiveness and aggregation of blood leukocytes were
observed within 1 h after thermal injury only to further increase up to 6 h and
then to gradually decrease and subside by 5 days after thermal injury. The degree
of leukocyte adhesiveness and aggregation correlated with the degree of pul-
monary leukostasis. We have noticed that all chemoattractants under study were
involved in the development of neutropenia, suggesting that these chemotactic
mediators are also involved, at least in the pulmonary accumulation of blood
neutrophils.
Based on the current studies, thermal injury results in activation of blood
neutrophils, the activation process appearing to be due to the action of chemo-
tactic mediators. The present data demonstrate that all chemoattractants studied
(C5a, PAF, KG, MIP-2) were involved in activation of blood neutrophils follow-
ing thermal injury, with C5a and PAF appearing to play a crucial role in early
activation events. These data indicate that neutrophil activation in the experi-
mental model is due to effects of C5a, chemokines and the lipid mediator PAF.
This would be consistent with the concept that thermal injury incites a “systemic
inflammatory response syndrome,” resulting in the appearance of several medi-
ators that cause inappropriate activation of blood neutrophils, setting the stage
for multi-organ injury.
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